M econium aspiration syndrome (MAS) is a respiratory disorder that affects term neonates. It occurs in 0.5-1.0 per 100,000 live births in industrialized countries. Twenty percent of these infants require intubation and to be mechanically ventilated and are defined as having severe MAS with an overall mortality rate of 7% (1) (2) (3) . Prolonged presence of meconium in the lung is critical in the pathogenesis and induces 1) mechanical obstruction of airways; 2) chemical alveolitis and epithelial damage; 3) pulmonary hypertension; and 4) inhibition of surfactant tensioactive properties (4 -7) . Infants with the most severe MAS must be rapidly transferred to a tertiary neonatal intensive care unit to receive the latest but not always evidencebased adjuvant therapies, including a number of exogenous surfactant therapies (43%), high-frequency gas ventilation (30%), or inhaled nitric oxide (36%) (3) . The ultimate alternative is extracorporeal membrane oxygenation. Although only approximately 2% of severe MAS meets the entry criteria for extracorporeal membrane oxygenation, MAS nevertheless remains the first cause of extracorporeal membrane oxygenation use in neonates and has a high success rate in MAS. However, in addition to being costly and not widespread, the use of extracorporeal membrane oxygenation in MAS is still discussed (8, 9) . Hence, despite advances over the last 20 yrs, MAS remains one of the most worrisome clinical conditions to manage.
Present-day research is exploring the use of therapeutic lung lavage, namely, the possibility of clearing the lung of meconium. Two clinical randomized controlled studies have explored the effects of lung lavages with diluted exogenous surObjective: To test the hypothesis that total liquid ventilation enables a more effective and better tolerated lavage than a bronchoalveolar lavage performed with diluted surfactant in a newborn ovine model of severe acute meconium aspiration syndrome.
Design: Prospective, randomized, interventional study. Setting: Animal research laboratory at the Faculté de mé decine et des sciences de la santé de l'université de Sherbrooke, Sherbrooke, Canada.
Subjects: Twenty-three newborn lambs, <4 days, 2.5-4.0 kg in weight.
Interventions: Animals were intubated, anesthetized, and paralyzed. Catheters were placed in the femoral artery and jugular vein. Severe meconium aspiration syndrome was obtained by instillation of a 25% dilution of human meconium in saline (1 mL/kg ؋ 2). Lambs were then randomized in 12 total liquid ventilation-bronchoalveolar lavage (minute ventilation of 160 mL/kg/min with perfluorodecalin) vs. 11 bronchoalveolar lavage performed with diluted surfactant (conventional ventilation ؉ 30 mL/kg in two aliquots bronchoalveolar lavage with 5 mg/mL BLES surfactant). Surviving lambs were ventilated for a total of 4 hrs and euthanized.
Measurements and Main Results: Arterial blood gases, systemic and pulmonary hemodynamic parameters using the thermodilution method, percentage of recovered meconium, and lung histologic scores. Total liquid ventilation bronchoalveolar lavage enabled a significantly higher PaO 2 throughout the experiment. PaCO 2 , pH, and hemodynamic parameters were comparable for both groups except for an increase in mean pulmonary arterial pressure during total liquid ventilation. Total liquid ventilation bronchoalveolar lavage allowed for 43 ؎ 14% of the instilled meconium to be removed vs. 28 factant (10, 11) . However, despite some encouraging preliminary results, the beneficial effects and the safety of such lavage procedures are far from proven considering the disappointing results recently obtained (11) . Overall, the challenge is to ensure both the efficacy and safety of the lavage procedure along with adequate ventilatory support (12) . One solution is liquid ventilation because previous studies have demonstrated its effectiveness in the management of acute experimental MAS (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . Although it was concluded that there was insufficient experimental evidence to advocate clinical use of liquid ventilation in severe MAS, total liquid ventilation (TLV) nonetheless appeared more effective than partial liquid ventilation or surfactant bolus treatment (13) . In addition, translation of this experimental data to bedside has been hampered by the lack of a suitable total liquid ventilator for clinical use.
In the present study, we tested the hypothesis that TLV using an advanced TLV device enables a more effective and better tolerated lavage procedure than a bronchoalveolar lavage performed with diluted surfactant (S-BAL) in a newborn lamb model of severe acute MAS.
METHODS
The present experimental protocol was approved by our institutional ethics committee for animal care and experimentation. Twentythree healthy term newborn lambs weighing (mean Ϯ SD) 2.5 Ϯ 0.3 kg and Ͻ4 days of age were premedicated with intramuscular injection of ketamine (10 mg/kg), atropine (0.1 mg/kg), and midazolam (0.1 mg/kg). Lambs were orally intubated with a 5.0-or 5.5-mm cuffed endotracheal tube (Mallinckrodt, St Louis, MO), restrained in a supine position under radiant heat to maintain a central temperature of 39 Ϯ 1°C, and then ventilated using conventional mechanical ventilation (Servo 300 ventilator; Siemens-Elema AB, Solna, Sweden) in a pressure-regulated, volume-controlled mode according to the following parameters: positive end expiratory pressure at 4 cmH 2 O, tidal volume at 10 mL/kg, fraction of inspired oxygen (FIO 2 ) at 0.35, respiratory frequency at 50 breaths/min, and inspiratory/expiratory ratio at 1:2. Heart rate was monitored using a Hewlett-Packard cardiorespiratory monitor (Model HP78342A; Palo Alto, CA). Oxygen saturation was monitored using a pulse oximeter probe placed on the base of the tail (Radical, Masimo, Irvine, CA). After cannulation of the right jugular vein (6-Fr catheter; Edwards LifeSciences, Irvine, CA), lambs were anesthetized with thiopental (initially with 20 mg/kg intraperitoneal, then sustained with 2 mg/kg/hr intravenous), paralyzed with an intermittent bolus of rocuronium bromide (0.1 mg/kg intravenous), and received a continuous intravenous infusion of 4 mL/kg/hr of 5% dextrose. Antibiotics (0.05 mg/kg duplocillin and 5 mg/kg gentamicin) were injected intramuscularly.
Surgery and Baseline Measurements. A 7-Fr thermodilution catheter (PV2047, VoLEF catheter; Pulsion Medical System, Munich, Germany) was inserted into the proximal pulmonary artery for pulmonary thermodilution measurements. A 3-Fr 7-cm femoral artery catheter (PV2013L07, PiCCO catheter; Pulsion Medical System, Munich, Germany) was installed using a cutdown procedure for transpulmonary thermodilution measurements and access for arterial blood gas analysis. After a 30-min recovery period, FIO 2 was elevated to 1 for 30 mins to obtain baseline parameters.
Meconium Aspiration Syndrome and Randomization. Severe MAS was induced with human meconium obtained from healthy babies, pooled, diluted to 25% in weight with saline, homogenized, and frozen for subsequent uses. Two milliliters per kilogram (13) was instilled through a 5-Fr feeding tube inserted in the endotracheal tube in two successive aliquots of 1 mL/kg with the head and chest of the lamb slightly inclined to the left and then to the right. Squeezing of the chest was performed during the procedure to ensure an homogeneous distribution. The goal was to reach severe MAS with a PaO 2 Յ100 mm Hg (under conventional mechanical ventilation at a FIO 2 of 1) after 30 mins. If these conditions were not obtained, the procedure was repeated with two aliquots of 0.5 mL/kg. Lambs were then randomly distributed into two groups.
Bronchoalveolar Lavage Performed With Diluted Surfactant (n ϭ 10). The first group was treated with a bronchoalveolar lavage using an exogenous surfactant dilution under conventional mechanical ventilation in the pressure-regulated, volume-controlled mode (positive end expiratory pressure ϭ 7 cm H 2 O, tidal volume ϭ 11 mL/kg, FIO 2 ϭ 1, respiratory frequency ϭ 50 breaths/min, inspiratory/ expiratory ratio ϭ 1:2). The ventilator was first disconnected and a dispensing catheter (12-Fr Levine catheter; Source Medical, PointeClaire, Quebec, Canada) through the endotracheal tube was used to administer a total of 30 mL/kg in two aliquots of exogenous surfactant BLES (Bles Biochemicals Inc, London, Ontario, Canada) at a dilution of 5 mg/mL of saline. The procedure was carried out with the head elevated and chest inclined to the left and then to the right. Then, the gas ventilator was reconnected and a vibratory chest squeeze was manually performed during expirations. Although a gentle vibratory chest squeeze was performed, a 12-Fr suction catheter was introduced into the endotracheal tube to retrieve the lavage liquid using a standard suction pressure (Ϫ150 mm Hg) (11) without lowering the head of the lamb. If lambs did not recover predetermined arterial saturation of 80%, the second lavage was not performed. The collected fluid was frozen for subsequent quantification of washed meconium.
Total Liquid Ventilation-Bronchoalveolar Lavage (n ϭ 10). For the second group, a TLV bronchoalveolar lavage was used using our specifically designed TLV prototype (Inolivent 4, University of Sherbrooke, Sherbrooke City, Quebec, Canada) (23, 24) . Tracheal pressure was measured at the distal end of the endotracheal tube using a stainless steel capillary tube connected to the pressure sensor (Model 1620; Measurement Specialties Inc, Hampton, VA). Lungs were filled at functional residual capacity (25 mL/kg) with warmed (39.0 Ϯ 0.5°C) preoxygenated perfluorodecalin (F2 Chemicals, Lancashire, UK). Filling was achieved in one-tenth increments of the functional residual capacity using a special function of Inolivent 4, whereas the same pressure-regulated, volume-controlled mode was conducted by the gas ventilator. A positive end expiratory pressure of 7 cm H 2 O was used. TLV was then initiated at the end of an expiration (respiratory frequency ϭ 5.35/min, tidal volume ϭ 20 mL/kg, inspiratory/expiratory ratio ϭ 1/3, FiO 2 ϭ 100%) (23, 24) . Tidal volume was then gradually raised to 30 mL/kg (25) . Meconium was filtered with a three-part (K-29595-03; K-29595-63; K-29595-41) filter (Cole-Parmer, Chicago IL) set on the expiratory tube. Retrieved material was frozen for subsequent quantification of washed meconium.
Both groups were ventilated for a total of 4 hrs after randomization.
Other Experimental Management. Sodium bicarbonate or tromethamine was used to maintain pH Ͼ7. 25 . Infusion of crystalloids (bolus of 10 mL/kg normal saline or lactated Ringer's solution) or dopamine (up to 20 g/ kg/min) was used as needed to maintain a mean arterial pressure Ն50 mm Hg. At the end of the protocol, the animals were euthanized with a lethal dose of pentobarbital (60 mg/kg) and the lung and thoracic cavity carefully inspected for evidence of perfluorothorax or gross abnormalities. The right lung of every lamb was perfused with 1/10 dilution of formaldehyde as a whole for histologic analysis.
Sampling and Data Analysis. Arterial blood gas analyses were conducted every 30 mins (Rapidlab 865; Bayer, Leverkusen, Germany). Parameter information from hemodynamic devices and both ventilators was synchronized and recorded onto our TLV prototype at 50 Hz through xPCtarget (Mathworks, Natick, MA) and compiled with Matlab (Mathworks). Hemodynamic parameters were standardized using body surface area calculated according to the following formula: weight 0.67 ϫ 0.084 (26) . The recovered meconium was lyophilized (Freezone 6 freeze dry system; LABCONCO, Kansas City, MO) and weighed to compare with a standard curve (preparation volume vs. dry weight). A correction factor (calculated in vivo with healthy lambs) was used to minimize any error resulting from other fluid recovery.
Macroscopic Observations and Lung Histology. Four sections of the right lung (two from the dependent zone and two from the nondependent zone) were embedded in paraffin. Slides were stained with hematoxylineosin and examined and scored by a doubleblind pathologist. The score included nine different parameters (14, 18) and was attributed according to quartile of presence (0 -4). Normal lamb lung was obtained from a newborn lamb ventilated up to baseline and euthanized before randomization.
Statistics. Results were analyzed by the statistician with the SAS 9.0 software (Version 9.0; SAS Institute Inc, Cary, NC) using a twofactor analysis of variance with repeated measures. Intra-and intergroup comparisons were adjusted with the Bonferroni method. For the PaO 2 variable as well as histologic results, the Mann-Whitney test was used to compare both groups because it was impossible to transform the data to obtain a normal distribution. Statistical significance was accepted at p values Ͻ .05. Results are expressed at mean Ϯ SD, except for histologic scores expressed as median (minimum, maximum).
RESULTS
Twenty-three lambs were randomized of which three died (two TLV-bronchoalveolar lavage [BAL] and one S-BAL) related to technical problems. The other 20 animals survived until the end of the experiment and were euthanized. One animal in each group received additional meconium (1 mL/kg). One lamb from the TLV group had a perfluorothorax, which was identified retrospectively during necropsy. There was no significant difference in that lamb results for oxygenation and CO 2 elimination. One lamb from the S-BAL group did not receive the second lavage in accordance with the experimental protocol. Removing this lamb from the data analysis had no effect on the results.
Gas Exchange. As shown in Figure 1 , except for a slight difference in arterial blood pH (TLV-BAL ϭ 7.422 Ϯ 0.048; S-BAL ϭ 7.357 Ϯ 0.042), animals of both groups were similar before randomization. After meconium instillation, all lambs had a PaO 2 Յ100 mm Hg under a FIO 2 of 1 and were classified as having severe MAS (TLV-BAL ϭ 84.4 Ϯ 7.5; S-BAL ϭ 80.4 Ϯ 15.6). There was no significant difference noted between the two groups at this stage. After randomization, measured PaO 2 rapidly increased for the TLV group and was maintained at a mean of 214 Ϯ 18 mm Hg throughout the experiment. In the S-BAL group, PaO 2 increased slowly to reach a mean of 104 Ϯ 19 mm Hg (Fig. 1A) . The difference was significant throughout except at the 120th min of the experiment. In addition, there was no observable statistical difference in PaO 2 level between baseline and the 240th min of the TLV-BAL group. There was a significant difference in arterial saturation values (Fig. 1D) between the two groups at several phases of the experiment including in the first few minutes of treatment (TLV-BAL: 99.2 Ϯ 0.3%; S-BAL: 80.1 Ϯ 18.8%). This increase in arterial saturation was maintained with TLV-BAL as opposed to S-BAL. After a slight decrease in PaCO 2 for both groups, there was no significant difference except at the 120th min of the experiment when PaCO 2 was slightly higher for the TLV-BAL (TLV-BAL ϭ 46.4 Ϯ 3.2 mm Hg; S-BAL ϭ 34.7 Ϯ 7.0) mm Hg (Fig. 1B) . There was no significant difference in pH values at any time during the treatments (Fig. 1C) .
Ventilatory Parameters. As shown in Table 1 , respiratory frequency and minute ventilation were lower for the TLV-BAL group as a result of the nature of the TLV technique. Mean airway pressure rose on induction of MAS in both groups. However, although mean airway pressure for S-BAL group remained elevated, mean airway pressure for the TLV-BAL group decreased rapidly and returned to baseline value. Hemodynamic Parameters. Table 2 shows that there was no significant difference with regard to mean systemic arterial pressure, cardiac index, heart rate, or systemic vascular resistance index before and after randomization between the two groups. In addition, there was no significant difference between groups relative to the use of dopamine and crystalloids (data not shown). MAS induced an increase in mean pulmonary arterial pressure and pulmonary vascular resistance index, both of which were significantly higher in the TLV-BAL group as compared with the S-BAL group from the 60th min onward after randomization.
Recovered Meconium. The amount of meconium recovered in the TLV group (43.3 Ϯ 13.8%) was significantly higher than the amount recovered in the S-BAL group (27.5 Ϯ 10.4%).
Histology. Scoring results from both dependent and nondependent lung sites were pooled because there were no significant differences among any of the scores (Table 3 ). There was no significant difference between dependent and nondependent parts of the lungs according to overdistension. Overdistension was scored significantly higher for the TLV group, whereas interstitial inflammation and alveolar hemorrhaging were both significantly higher for the S-BAL group. Histology of dependent and nondependent sites for both groups as well as a negative control is shown in Figure 2 .
DISCUSSION
The present study demonstrates that, in comparison to S-BAL, TLV-BAL in this acute MAS model is well tolerated, provides better gas exchange, and enables larger meconium washout along with a similar histologic total score. Hemodynamic measurements were identical apart from mean pulmonary arterial pressure, which was significantly higher in the TLV-BAL group.
The newborn ovine acute MAS model used in the present study is similar to a number of ovine (13, 27) and other animal (14, 16, 17, 21) models. Furthermore, this model is very reproducible and well representative of MAS in human newborns with all its complications (1).
Promptness of support and treatment for a patient with severe MAS is the key in resolving morbidity and mortality (1). MAS induction results in alarming gas exchange and is responsible for the rise in mean pulmonary arterial pressure that ultimately leads to typical persistent pulmonary hypertension often linked to this pathology. Both groups here had identically severe Table 1 . Ventilation parameters measured at each phase of the experiment presented as mean Ϯ SD for the TLV-BAL group (n ϭ 10) and S-BAL group (n ϭ 10) TLV-BAL, total liquid ventilation bronchoalveolar lavage; S-BAL, bronchoalveolar lavage with diluted surfactant; MAS, meconium aspiration syndrome; Fr, respiratory frequency; Vt, tidal volume; Vmin, minute ventilation; PEEP, positive end expiratory pressure; Paw, mean airway pressure; Ppeak, peak pressure. a p Յ .05 (intergroups). TLV-BAL, total liquid ventilation bronchoalveolar lavage; S-BAL, bronchoalveolar lavage with diluted surfactant; MAS, meconium aspiration syndrome; APm, mean arterial pressure; CIa, indexed cardiac output; HR, heart rate; SVRI, systemic vascular resistance index; PAPm, mean pulmonary arterial pressure; PVRI, pulmonary vascular resistance index. a p Յ .05 (intergroups).
acute deterioration of their condition after MAS induction. As pointed out in many preclinical studies, clearing the lung from meconium using an effective lavage volume of diluted surfactant improves the outcome in MAS (12, 14, 28) . S-BAL therapy in itself washes the meconium, but, as a result of the nonoxygenated liquid, transiently raises the level of respiratory distress before significant improvement is possible (11) . In comparison, TLV-BAL in this study aimed at lavaging the meconium while providing steady adequate ventilation. Arterial saturation levels shown in Figure 1D clearly demonstrate that TLV enabled recovery of oxygenation after only 5 mins. Conversely, S-BAL necessitated 30 mins to 1 hr before allowing the lambs to reach an acceptable level of oxygenation, even with the reportedly optimal use of surfactant, including for concentration, number of aliquots, and total volume injected (28) . Furthermore, TLV-BAL allowed more rapid and better oxygenation than S-BAL throughout the 4-hr experiment. Indeed, PaO 2 levels were doubled during TLV compared with the conventional mechanical ventilation that followed S-BAL. Similar results were also shown in a previous study in newborn lambs (13) . This huge difference in oxygenation levels between TLV and S-BAL lambs was not accompanied, however, by lower PaCO 2 levels. Indeed, CO 2 removal tended to be better in the S-BAL group than in the TLV group (statistically significant at the 120th min). Nevertheless, average levels of PaCO 2 remained within an acceptable clinical range in both groups and pH values did not show any significant difference. It should be noted, however, that better gas exchanges during TLV were obtained at a much lower ventilator pressure across the ventilator cycle, as demonstrated by the significantly lower mean airway pressure. In addition, as a consequence of the high viscosity of perfluorocarbon, proximal airway pressures are rapidly dissipated along the airways during TLV resulting in much lower alveolar pressure than tracheal pressure (29) . Overall, results of this study and the literature (30) suggest that TLV has a potential for protecting the lung against ventilator-induced lung injury.
The S-BAL group had no problem in recovering baseline mean pulmonary arterial pressure (PAPm) 1 hr after onset of treatment. Our main concern is the significantly higher PAPm level observed during TLV. As shown by others, large tidal volumes used in TLV most likely lead to an increase in intrathoracic pressure with a subsequent increase in alveolar capillary pressure (31) . A major complication of severe MAS is the development of persistent pulmonary hypertension of the newborn and therefore controlling or reversing persistent pulmonary hypertension of the newborn is a major goal of all new proposed MAS therapies. In the present study, PAPm and pulmonary vascular resistance index both increased by approximately 50% after meconium instillation in both groups and tended to be higher in the TLV-BAL group as opposed to S-BAL, although not significantly. However, despite the dramatic improvement in gas exchange, the present study failed to show any improvement in PAPm or pulmonary vascular resistance index levels at the 240th min Table 3 . Median histologic score (minimum, maximum) for both groups (S-BAL and TLV-BAL) S-BAL (n ϭ 10) TLV-BAL (n ϭ 10) of TLV-BAL. This absence of improvement has been described previously in both TLV (13, 31) and partial liquid ventilation (13, 17) and may be the result of the compression of small pulmonary vessels by perfluorocarbon-filled alveoli (32) . Although intrapulmonary administration of vasoactive drugs (33) or decreasing end expiratory pressure could be used to address the increase in PAPm, it must be emphasized that this relatively high PAPm in TLV did not impair gas exchanges or the overall systemic hemodynamic parameters. Improvement in gas exchange in the liquid-filled lung described in the present study may be explained by a combination of different mechanisms, including an increase in alveolar recruitment, better lung compliance as well as an increase in transalveolar pressure in dependent lung regions resulting in redistribution of pulmonary blood flow to the nondependent regions. This combination of mechanisms has been demonstrated to improve ventilation/perfusion matching by homogeneously redistributing regional pulmonary blood flow (13, 20, 32, 34) .
In the present study, there is an important difference in meconium recovery between the S-BAL and TLV-BAL groups. Because preoxygenated perfluorodecalin, like for all perfluorocarbons, is not miscible with water and is very dense, meconium solids are easily removed during TLV. It is likely that the weight of preoxygenated perfluorodecalin also enables to wash out meconium in the dependent sites of the lungs. This result was somewhat anticipated after only a few experiments because the fluid recovered after S-BAL contained mainly diluted meconium. By diluting the meconium, it is likely that S-BAL washes out a portion of the debris, but in turn also homogenizes the entire lungs with what is left of the meconium. Furthermore, it should be emphasized that some meconium remained in the tubing of the TLV device (before the filter), therefore indicating that TLV-BAL actually washed out more meconium than indicated. The meconium recovered in this study using TLV lavage is very close to the best results obtained by others using therapeutic lung lavage with diluted surfactant (11, 12) . However, the different methods used for quantification of the meconium as well as the report of either meconium or lavage fluid recovery complicates the comparison with the previously published studies (28) .
A 4-hr protocol may be too short to observe clear changes in the histologic profile. Slight differences were observed as shown in the photomicrographs (Fig. 2) , notably regarding the higher presence of meconium deposit for the S-BAL group. An increase in the overdistension histologic score was also noted for the TLV-BAL group. None of the three previous studies in TLV during MAS has reported such a histologic overdistension score (13, 20, 21) . Histology scores for the S-BAL group were comparable to those reported in the literature (18) .
Some limitations of our work must be acknowledged: 1) given that our study specifically aimed at testing the hypothesis that TLV is more effective than S-BAL to treat a severe MAS, a gasventilated MAS control group was not deemed necessary. Of note, previous results in a gas-ventilated MAS model have been reported (13); 2) our present results in the S-BAL group may appear somewhat worse than in previous studies using beractant, a mince lung surfactant (12, 14) . However, BLES, a natural surfactant derived from lung lavage, has been found at least as resistant to inactivation in the presence of meconium as lung mince surfactant (35, 36) . Furthermore, its efficacy for therapeutic lung lavage has been demonstrated in a rabbit model of MAS (37) . An alternate explanation for our worse results (than previously) in the S-BAL group would be related to differences in animal species; 3) finally, the most significant limitation of our study may be its short duration with no attempt to wean lambs back to gas ventilation.
In conclusion, we demonstrate here the better efficacy of TLV-BAL comparatively to S-BAL in our short-term experimental settings. The results obtained together with the recent progress achieved in the design of a user-friendly fully controlled automated and safe liquid ventilator (38) advocate for further experiments in our ovine model, ultimately aiming at a clinical trial with TLV-BAL to treat severe MAS.
